Please find enclosed herewith the revised Investor presentation
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shanmuga Hospital has refiled its investor presentation with BSE to correct inadvertent errors in patient volume data. The number of inpatients was revised from 19,741 to 25,440, and outpatients from 5,699 to 43,053 — a substantial correction. The presentation covers the multi-specialty hospital in Salem, Tamil Nadu, with 150+ bed capacity, NABH/NABL accreditations, and advanced technology like Da Vinci Xi robotic surgery and two LINAC machines. FY25 revenue stood at ₹47.85 crore with EBITDA of ₹8.17 crore and PAT of ₹4.20 crore. The company outlined growth plans including adding 50 beds, launching renal transplant services, opening a Nephro Care Center, and introducing a digital health app. The stock trades at ₹46.10 with a market cap of ₹62.76 crore.
The correction of patient footfall numbers (especially outpatients, which jumped over 7x) may raise questions about the accuracy of originally disclosed data, though the revised numbers are more consistent with the hospital's 150-bed scale. For shareholders, the revised presentation now provides a clearer, more credible picture of operational scale, while growth initiatives in renal care and digital health signal expansion plans.